期刊
CANCER AND METASTASIS REVIEWS
卷 35, 期 3, 页码 377-390出版社
SPRINGER
DOI: 10.1007/s10555-016-9630-4
关键词
Exosome; Sarcoma; Biomarker; Targetedcancer therapy
类别
资金
- Gattegno and Wechsler funds
- Kenneth Stanton Fund
- Jennifer Hunter Yates Foundation
- Sarcoma Foundation of America (SFA)
- National Cancer Institute (NCI)/National Institutes of Health (NIH) [UO1, CA151452-01]
Better diagnostic biomarkers and therapeutic options are still necessary for patients with sarcomas due to the current limitations of diagnosis and treatment. Exosomes are small extracellular membrane vesicles that are released by various cells and are found in most body fluids. Tumor-derived exosomes have been proven to mediate tumorigenesis, intercellular communication, microenvironment modulation, and metastasis in different cancers, including in sarcomas. Recently, exosomes have been considered as potential biomarkers for sarcoma diagnosis and prognosis, and as possible targets for sarcoma therapy. Moreover, due to their specific cell tropism and bioavailability, exosomes can also be engineered as vehicles for drug delivery. In this review, we discuss recent advances in the roles of tumor-derived exosomes in sarcoma and their potential clinical applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据